SREBF1 and hepatocellular carcinoma: Among them, sterol-regulatory element binding protein 1c (SREBP1c) is well established as a key marker and therapeutic target for hepatosteatosis, because transgenic over-expression of this bHLH-ZIP factor leads to hepatosteatosis, but not hepatoma [9].